Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote RadioresistanceStephen V Carney, Kaushik Banerjee, Anzar Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Nature Communications|January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene TherapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to RadiationFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
The Journal of Clinical Investigation|September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma modelsSantiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
Nature Communications|August 1, 2020
Purine metabolism regulates DNA repair and therapy resistance in glioblastomaWeihua Zhou, Yangyang Yao, Andrew J Scott, et al.
NPJ Precision Oncology|August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizonCameron Crowell, Ziwen Zhu, Yingxiang Li, et al.
Pageof 21